ArticleMedicine in drug discovery2024

Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy.

Rahul Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.